NIH-funded research P01 program project

Understanding how gut bacteria affect Candida growth in the digestive system

Official title: Metabolic Regulation of Candida GI Tract Colonization

Funded at Sloan-Kettering Inst Can Research · NIH-11061785 · Data updated 2026-11-12

This study is looking at how the good bacteria in your gut and their byproducts can help stop the growth of Candida yeast, which can cause infections, and it aims to find new ways to help people manage these conditions.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionSloan-Kettering Inst Can Research
NIH-funded
Lab location1 site (New York, United States)
Project startApril 1, 2024
Project endMarch 31, 2029
Funding year2025
Award (this year)$541,200
NIH project number5P01AI179406-02
Project IDNIH-11061785 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adults undergoing allogeneic hematopoietic cell transplantation or those with gastrointestinal Candida infections.

Less likely to help

Patients who do not have Candida infections or are not undergoing treatments that affect their gut microbiota may not benefit from this research.

What this research studies

This research investigates how the gut microbiota and its metabolites influence the colonization of Candida, a type of yeast, in the gastrointestinal tract. The study employs both in vitro and in vivo methods to identify specific short-chain and medium-chain fatty acids that may inhibit Candida growth. By analyzing fecal samples from patients, the research aims to uncover the mechanisms behind Candida colonization resistance and how gut bacteria can help prevent infections. This could lead to new strategies for managing Candida-related conditions in patients.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for Candida infections by harnessing the power of gut bacteria.

How similar studies have gone: Previous research has shown promising results in understanding the role of gut microbiota in fungal infections, indicating that this approach could yield valuable insights.

Where this research is happening

  • Sloan-Kettering Inst Can Research
    New York, United States
    Active

Researchers

  • Principal investigator: Hohl, Tobias M — Sloan-Kettering Inst Can Research
  • Study coordinator: Hohl, Tobias M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.